Patients undergoing immune modulatory therapies for the treatment of autoimmune diseases such as multiple sclerosis, and individuals with an impaired-immune system, most notably AIDS patients, are in the high risk group of developing progressive multifocal leukoencephalopathy , a fatal demyelinating disease of the white matter caused by human ... (more)
http://www.virologyj.com/content/10/1/147/abstract
http://www.virologyj.com/content/10/1/147/abstract
No comments:
Post a Comment